Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations

Journal of Magnetic Resonance Imaging

Volumn 16, Issue 4, 2002, Pages 394-406

  Aime, Silvio ^a   Cabella, Claudia ^b   Colombatto, Sebastiano ^c   Crich, Simonetta Geninatti ^a   Gianolio, Eliana ^a   Maggioni, Fabio ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b Bracco Imaging SpA   (Italy)

^c Dipartimento di Medicina e Oncologia Sperimentale   (Italy)

Author keywords

Cellular uptake; Gd(III) complexes; Molecular imaging; MRI; Relaxivity

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 4 CARBOXYAMIDO 3,2 HYDROXYPYRIDINONE; APOFERRITIN; AVIDIN; BETA CYCLODEXTRIN; BETA GALACTOSIDASE; BIOTIN; CONTRAST MEDIUM; GADOBENIC ACID; GADOLINIUM; GADOLINIUM PENTETATE; GADOTERIC ACID; LIGAND; MELANIN; METAL COMPLEX; UNCLASSIFIED DRUG;

ANGIOGENESIS; CELL MEMBRANE; CONTRAST ENHANCEMENT; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG UPTAKE; ENZYME ACTIVITY; HUMAN; INTERNALIZATION; LIVER CELL; MAGNETIC FIELD; MOLECULAR BIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTOSIS; PHANTOM; PRIORITY JOURNAL; REVIEW; SOLUBILIZATION;

ANIMALS; CONTRAST MEDIA; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036794367     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10180     Document Type: Review

References (51)

1. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001: 219:316-333.
2. Caravan P, Ellison Jj, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics and applications. Chem Rev 1999;99:2293-2352.
3. Toth E, Helm L, Merbach AE. Relaxivity of gadolinium(III) complexes: theory and mechanism. In: Merbach AE, Toth E, editors. The chemistry of contrast agents in medical magnetic resonance imaging. Chichester: John Wiley & Sons. LTD: 2001. p 45.
4. Aime S, Botta M, Fasano M, Terreno E. Protein-bound metal chelates. In: Merbach AE, Toth E, editors. The chemistry of contrast agents in medical magnetic resonance imaging. Chichester: John Wiley & Sons, Ltd; 2001. p 193.
5. Andre JP, Toth E, Fischer H, Seelig A, Macke HR, Merbach AE. High relaxivity for monomeric Gd(DOTA)-based MRI contrast agents. thanks to micellar self-organization. Chem Eur J 1999;5:2977-2983.
6. Aime S, Botta M, Garino E, et al. Non-covalent conjugates between cationic polyamino acids and Gd-III chelates: a route for seeking accumulation of MRI-contrast agents at tumor targeting sites. Chem Eur J 2000;6:2609-2617.
7. Bligh SW, Harding CT, Sadler PJ. et al. Use of paramagnetic chelated metal derivatives of polysaccharides and spin-labeled polysaccharides as contrast agents in magnetic resonance imaging. Magn Reson Med 1991;17:516-532.
8. Wiener EC, Brechbiel MW, Brothers H, et al. Dendrimer based metal chelates-a new class of magnetic resonance imaging contrast agents. Magn Res Med 1994;31:1-8.
9. Merbach AE. Toth E. In: Merbach AE, Toth E. editors. The chemistry of contrast agents in medical magnetic resonance imaging. Chichester: John Wiley & Sons, Ltd; 2001.
10. Pubanz D, Gonzalez G, Powell DH, Merbach AE. Unexpectedly large change of water exchange-rate and mechanism on [Ln(DTPA-BMA)(H20)] complexes along the lanthanide(III) series. Inorg Chem 1995;34:4447-4453.
11. Aime S, Botta M, Fasano M, Terreno E. Prototropic and waterexchange processes in aqueous solutions of Gd(III) chelates. Acc Chem Res 1999;32:941-949.
12. Aime S, Botta M, Fasano M. Terreno E. Lanthanide(III) chelates for NMR biomedical applications. Chem Soc Rev 1998;27:19-29.
13. Clarkson RB, Smirnov AI, Smirnova TI, Belford RL. Multi frequency and high-frequency EPR methods in contrast agent research: examples from Gd(III) chelates. In: Merbach AE, Toth E, editors. The chemistry of contrast agents in medical magnetic resonance imaging. Chichester: John Wiley & Sons, LTD; 2001. p 383.
14. Aime S, Gianolio E, Terreno E, et al. Ternary Gd(III)L-HSA adducts: evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI. J Biol Inorg Chem 2000;5:488-497.
15. Aime S, Botta M, Bruce JI, Mainero V, Parker D, Terreno E. Modulation of the water exchange rates in [Gd-DO3A] complex by formation of ternary complexes with carboxylate ligands. Chem Commun 2001;1:215-216.
16. Sunderland CJ, Botta M, Aime S, Raymond KN. 6-carboxamido-5,4-hydroxypyrimidinones: a new class of heterocyclic ligands and their evaluation as gadolinium agents. Inorg Chem 2001;40:6746-6756.
17. Hajela S, Botta M, Giraudo S, Xu J, Raymond KN, Aime S. A tris-hydroxymethyl-substituted derivative of Gd-TREN-Me-3,2-HOPO: an MRI relaxation agent with improved efficiency. J Am Chem Soc 2000;122:11228-11229.
18. Aime S, Botta M, Frullano L, et al. [GdPCP2A(H2O)(2)](-); a paramagnetic contrast agent designed for improved applications in magnetic resonance imaging. J Med Chem 2000;43:4017-4024.
19. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996;1275:161-203.
20. Webb B, Frame J, Zhao Z, Lee ML, Watt GD. Molecular entrapment of small molecules within the interior of horse spleen ferritin. Arch Biochem Biophys 1994;309:178-183.
21. Aime S, Geninatti Crich S, Frullano L. Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew Chem Int Ed Eng 2002;114:1059-1061.
22. Curtet C, Maton F, Havet T. Polylysine-Gd-DTPA(n) and polylysine-Gd-DOTA(n) coupled to anti-CEA F(ab′)(2) fragments as potential immunocontrast agents-relaxometry, biodistribution, and magnetic resonance imaging in nude mice grafted with human colorectal carcinoma. Invest Radiol 1998;33:752-761.
23. Casali C, Janier M, Canet E. Evaluation of Gd-DOTA-labeled dextran polymer as an intravascular MR contrast agent for myocardial perfusion. Acad Radiol 1998;5:214-218.
24. Wiener EC, Konda S, Shadron A, Brechbiel M, Gansow O. Targeting dendrimer-chelates to tumors and tumor cells expressing the highaffinity folate receptor. Invest Radiol 1997;32:748-754.
25. Kabalka GW, Davis MA, Moss TH, et al. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver. Magn Reson Med 1991;19:406-415.
26. Gohrrosenthal S, Scmittwillich H, Ebert W, Conrad J. The demonstration of human tumors on nude mice using gadolinium labeled monoclonal antibodies for magnetic resonance imaging. Invest Radiol 1993;28:789-795.
27. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KCP. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 1998;4:623-626.
28. Lemieux GA, Yarema KJ, Jacobs CL, Bertozzi CR. Exploiting differences in sialoside expression for selective targeting of MRI contrast reagents. J Am Chem Soc 1999;121:4278-4279.
29. Bogdanov A, Matuszewski L, Bremer C, Petrovsky A, Weissleder R. Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Molec Imaging 2002;1:16-23.
30. Aime S, Botta M, Fedeli F, Gianolio E, Terreno E, Anelli PL. Highrelaxivity contrast agents for magnetic resonance imaging based on multisite interactions between a beta-cyclodextrin oligomer and suitably functionalized Gd-III chelates. Chem Eur J 2001;7:5261-5269.
31. Hunter CA, Sanders JKM. The nature of pi-pi interactions. J Am Chem Soc 1990:112:5525.
32. Nunn AD, Linder KE, Tweedle F. Can receptors be imaged by nuclear magnetic resonance? Q J Nucl Med 1997;41:155-162.
33. Ahrens ET, Rothbacher U, Jacobs RE, Fraser SE. A model for MRI contrast enhancement using T-1 agents. Proc Natl Acad Sci USA 1998;95:8443-8448.
34. Schmalbrock P, Hines JV, Lee SM, Ammar GD, Wing-Chi Kwok E. T1 measurements in cell cultures: a new tool for characterizing contrast agents at 1.5T. J Magn Reson Imag 2001;14:636-648.
35. Colet JM, Lecomte S, Vander Elst L, Muller RN. Cesium-133: a potential reporter of the hepatic uptake of contrast agents. Magn Reson Med 2001;45:711-715.
36. Osterloh K, Aisen P. Pathways in the binding and uptake of ferritin by hepatocytes. Biochim Biophys Acta 1996;1275:161-203.
37. Fargion S, Arosio P, Fracanzani AL, et al. Characteristics and expression of binding sites specific for ferritin H-chain on human cell lines. Blood 1988;71:753-757.
38. Fargion S, Fracanzani AL, Brando B, et al. Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood 1991;78:1056-1061.
39. Bhorade R, Weissleder R, Nokakoshi T, Moore A, Tung CH. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjugate Chem 2000;11:301-305.
40. Roberts S, Bomford A. Ferritin iron kinetics and protein turnover in K562 cells. J Biol Chem 1988;263:19181-19187.
41. Konijn AM, Glickstein H, Vaisman B, et al. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood 1999;94:2128-2134.
42. Hill SE. Oxygen therapeutics-current concepts. Can J Anesth 2001;48:32-40.
43. Weissleder R, Cheng H, Bogdanova A, Bogdanov A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997;7:258-263.
44. Kavyem JF, Kumar RM, Fraser SE, Maede TJ. Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem Biol 1995;2:615-620.
45. Kobayashi H, Kawamoto S, Saga T, et al. Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI. Bioconjugate Chem 2001;12:587-593.
46. Aime S, Botta M, Geninatti Crich S, Giovenzana G, Palmisano G, Sisti M. A macromolecular Gd(III) complex as pH-responsive relaxometric probe for MRI applications. Chem Commun 1999;16:1577-1578.
47. Zhang S, Wu K, Sherry AD. A novel pH-sensitive MRI contrast agent. Angew Chem Int Ed Engl 1999;38:3192-3194.
48. Lowe MP, Parker D, Reany O, et al. pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J Am Chem Soc 2001;123:7601-7609.
49. Aime S, Ascenzi P, Comoglio E, Fasano M, Paoletti S. Molecular recognition of R-states and T-states of human adult hemoglobin by a paramagnetic Gd(III) complex by means of the measurement of solvent water proton relaxation rate. J Am Chem Soc 1995;117:9365-9366.
50. Burai L, Toth E, Seibig S, Scopelliti R, Merbach AE. High-pressure NMR kinetics, part 95-solution and solid-state characterization of Eu-II chelates: a possible route towards redox responsive MRI contrast agents. Chemistry 2000;6:3761-3770.
51. Moats RA, Fraser SE, Meade TJ. A "smart" magnetic resonance imaging agent that reports on specific enzymatic activity. Angew Chem Int Ed Eng 1997;36:726-728.